58
Views
38
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, Spectroscopic and Electrochemical Studies of Isomeric Dichloro-bis-[ N (1)-Alkyl-2-(Arylazo)Imidazole]-Osmium(II). Single Crystal X-ray Structures of Blue-Violet Dichloro-Bis-[ N (1)-Methyl-2-(Arylazo)Imidazole]-Osmium(II) Species

, , , , , & show all
Pages 479-496 | Published online: 15 Sep 2010
 

1-Alkyl-2-(arylazo)imidazoles (p-R-C6H4-N=N-C3H2N2X, abbreviated as RaaiX, R = H(a), CH3(b), Cl(c); X = N(1)-CH3 (1), N(1)-CH2-C6H5 (2)) have been reacted with (NH4)2[OsCl6] and OsCl2(RaaiX)2 species isolated in two isomeric forms, blue-violet (3, 5) and red-violet (4, 6). IR spectra show two x (Os-Cl) modes and support a cis-OsCl2 configuration. X-ray diffraction methods were used to determine structures of blue-violet isomers. In terms of the three coordination pairs around Os(II), Cl, Cl, N, N (N(imidazole), N) and N', N' (N(azo), N') the blue-violet isomers have a cis-trans-cis (ctc) configuration. 1H NMR data for the red-violet complexes (isomers B) and results concerning analogous ruthenium(II) complexes indicate isomer B to have cis-cis-cis (ccc) configuration. Absorption spectra show an intense MLCT band at ca 580 nm along with two weak bands at 800 and 1000 nm. Cyclic voltammetry shows quasi-reversible Os(III)/Os(II) and Os(IV)/Os(III) couples at 0.4-0.6 V and 1.3-1.5 V versus SCE and ill-defined azo reductions. The X-Ray structures show unusually long N=N bond lengths, 1.31-1.32 Å, elongated by some 0.06 Å compared to the free ligand value. Os(II) prefers to bind N(azo) (Os-N(azo), 1.98 Å) rather than N(imidazole) (Os-N(imidazole), 2.03 Å). EHMO calculations of ctc-OsCl2 (MeaaiMe) and comparison with the ruthenium(II) complex account for the MLCT transitions in terms of a metal-dominated HOMO to a ligand-dominated LUMO shift.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.